| scholarly article | Q13442814 |
| P50 | author | Paolo Vineis | Q25999450 |
| Magnus Ingelman-Sundberg | Q5823202 | ||
| Loic Le Marchand | Q28360612 | ||
| Seymour Garte | Q53335301 | ||
| Simone Benhamou | Q56427646 | ||
| Dorota Butkiewicz | Q58857312 | ||
| Emanuela Taioli | Q59826964 | ||
| Ingolf Cascorbi | Q60643608 | ||
| Bernadette Schoket | Q87418119 | ||
| Agneta Rannug | Q91502661 | ||
| Chikako Kiyohara | Q92973612 | ||
| Roberta Pastorelli | Q106393140 | ||
| Aage Haugen | Q114337741 | ||
| Marjorie Romkes | Q114384031 | ||
| P2093 | author name string | Haruhiko Sugimura | |
| Richard C Strange | |||
| Masahiro Kihara | |||
| Margie L Clapper | |||
| Isabelle Stucker | |||
| Fabrizio Veglia | |||
| Peter Shields | |||
| Ari Hirvonen | |||
| Laura Gaspari | |||
| Vita Dolzan | |||
| Pierre Kremers | |||
| Susumu Ohshima | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 650-657 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls | |
| P478 | volume | 104 |
| Q28393099 | Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report |
| Q33936367 | Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention |
| Q89621705 | Association of the G134A and G184C Polymorphisms in the CYP1A1 Gene with Lung Cancer Incidence |
| Q36473507 | CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates |
| Q33988992 | CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study |
| Q33678298 | CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study |
| Q35012051 | Causal models in epidemiology: past inheritance and genetic future |
| Q36481104 | Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer |
| Q34320848 | Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk |
| Q34572870 | Cigarette smoking: cancer risks, carcinogens, and mechanisms |
| Q35728797 | Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study |
| Q46896451 | Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects |
| Q33655625 | Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China |
| Q39522949 | Cytogenetic evaluation and the association with polymorphisms of the CPY1A1 and NR1I3 genes in individuals exposed to BTEX. |
| Q46653404 | EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women |
| Q22306069 | Epidemiology of Lung Cancer |
| Q37190263 | Gene-environment interaction in tobacco-related cancers |
| Q34421971 | Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias |
| Q57252090 | Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers |
| Q37174313 | Genetic susceptibility to cancer: the role of polymorphisms in candidate genes |
| Q26852320 | Genetic susceptibility to lung cancer--light at the end of the tunnel? |
| Q35868053 | Genetic susceptibility to tobacco-related cancer |
| Q35868045 | Individual susceptibility to carcinogens |
| Q79244001 | Locus‐specific genetic diversity between human populations: An analysis of the literature |
| Q37015996 | Lung cancer susceptibility: are we on our way to identifying a high-risk group? |
| Q36260511 | NQO1, MPO, and the risk of lung cancer: a HuGE review |
| Q46636112 | Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction. |
| Q43785146 | Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk |
| Q35980965 | Progress in the epidemiological understanding of gene-environment interactions in major diseases: cancer |
| Q36843606 | Quantitation of N-acetyl-S-(9,10-dihydro-9-hydroxy-10-phenanthryl)-L-cysteine in human urine: comparison with glutathione-S-transferase genotypes in smokers. |
| Q51370330 | Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population. |
| Q47329031 | Sequence similarities of protein kinase substrates and inhibitors with immunoglobulins and model immunoglobulin homologue: cell adhesion molecule from the living fossil sponge Geodia cydonium. Mapping of coherent database similarities and implicatio |
| Q92441742 | Sex-specific SNP-SNP interaction analyses within topologically associated domains reveals ANGPT1 as a novel tumor suppressor gene for lung cancer |
| Q33738492 | Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium |
| Q30250217 | Susceptibility to human cancer: From the perspective of a pathologist |
| Q36103367 | Who is at high risk for lung cancer? Population-level and individual-level perspectives |
Search more.